Norway / Staking a Claim as a Pharma Research Hub
Norway, more well-known internationally as an innovation hub for oil & gas and marine biology, is attempting to…
Cancer
CEE / EU’s Beating Cancer Plan: Making it Our Own
Jasper Kunow, MSD’s managing director for Central Eastern Europe, outlines the threat that cancer still poses to Europe, the challenges of enacting the EU’s Beating Cancer Plan across the CEE…
Oncology / MSD SVP Deepak Khanna: Taking a Europe-Wide Approach in the Fight Against Cancer
There are over 3.5 million diagnoses and 1.3 million deaths from cancer in the EU each year and cancer is set to…
Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
In Conversation
Dae Ho Lee – Professor, Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, South Korea
Professor Dae Ho Lee has been researching and treating Korean cancer patients for more than 20 years and advises the current government on healthcare policy. He breaks down the benefits of MoonCare to cancer patients, the challenges facing the healthcare system, and offers some potential solutions that could be adopted in the future. The Korean government is developing action…
Japan / Oncology Market Snapshot 2021
While the overall Japanese pharma market is expected to remain at a similar overall value up to 2023, the oncology…
Related Report
Norway / Staking a Claim as a Pharma Research Hub
Norway, more well-known internationally as an innovation hub for oil & gas and marine biology, is attempting to…
Korean Research Team Develops Nanoparticle for Cancer Treatment
A Korean research team at Ulsan National Institute of Science and Technology (UNIST) have developed a cunning…
Hot Topics / Chinese Biotech
PharmaBoardroom sat down with more than 25 biotech CEOs in China in 2019. We analyzed the contents of the…
Celltrion Wins Big Deal for Breast Cancer Biosimilar in French Hospitals
Celltrion Healthcare, the marketing arm of the biopharmaceutical company Celltrion won a huge deal in France last…
News Roundup / Mexican Pharma: February 2020
Below is a selection of top recent news from Mexican pharma and healthcare, including the healthcare reforms…
Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…
The Impact of Next Generation Sequencing on Women-Focused Cancers
Kamala Maddali, vice president for Biopharma Collaborations & Companion Diagnostics at Cancer Genetics,…
Chinese PD-1 Cancer Drugs: Global Competition for Big Pharma
PD-1 inhibitors have boosted survival rates for many cancer patients since their introduction in the US five years…
CEE / East vs West: Bridging the Access Gap in European Cancer Care
From her vantage point as associate vice president for MSD’s Central & Eastern Europe (CEE) cluster,…
Oncology / Sweden's Excellence in Cancer Care: Behind the Figures
Key stakeholders in Swedish pharma explain why Sweden’s record on cancer care is the best in Europe and what…
Peru: Better Cancer Survival Rates Than Europe or the US
Despite Peru’s sometimes-sluggish development when it comes to healthcare, the progression of cancer prevention…
Cancer / Oncology Care in Hungary: In Need of Reform
Cancer is on the rise in Hungary and survival rates are considerably lower than the European average. The…
CEE / EU’s Beating Cancer Plan: Making it Our Own
Jasper Kunow, MSD’s managing director for Central Eastern Europe, outlines the threat that cancer still poses to…
Proposed Solutions to the Access Challenges Facing Cancer Medicines in Europe
Janssen’s EMEA market access head Martin Price outlines the regulatory changes that need to be made for…
Oncology / Switzerland: Fresh Tactics in the War on Cancer
With cancer now causing one in eight deaths globally and, in Europe, even outpacing serious cardiovascular…
Turkey: The Future of Cancer Care Uncertain
Turkey has one of the most revered Social Security Systems in the world, providing its citizens with…
Mexico / Bayer Targets Cancer; Novartis Gets Aggressive; J&J Vaccines Arrive; Doctors Denied Jabs
The latest news from Mexican pharma, including Bayer’s big bet on oncology and Novartis’ aggressive expansion…
Novartis: EU approve gene-modifying cancer therapy
This week Novartis received approval from the European Commission (EC) for Kymriah, their chimeric antigen…
Oncology / MSD SVP Deepak Khanna: Taking a Europe-Wide Approach in the Fight Against Cancer
There are over 3.5 million diagnoses and 1.3 million deaths from cancer in the EU each year and cancer is set to…